Company news
Grand Pharmaceutical Group Limited (HKEX:512) news
Grand Pharmaceutical Group Limited news releases on 6ix. Latest, May 7, 2025: The world's first: Grand Pharma's global innovative product STC3141 successfully…
Press releases & updates
The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China
May 7, 2025
VOLUNTARY ANNOUNCEMENT: THE GLOBAL INNOVATION PRODUCT OF THE GROUP STC3141 WAS APPROVED TO COMMENCE PHASE IIa CLINICAL RESEARCH IN RELATED TO COVID-19 IN BELGIUM
April 19, 2021
China Grand Pharmaceutical and Healthcare : GP (HK)'s First-In-Class Drug STC3141 for Sepsis has been granted A 'Notice of Approval for Clinical Trial of Drugs' issued by the NMPA
March 4, 2021
China Grand Pharmaceutical and Healthcare : GP (HK)'s Independently Developed Innovative Glaucoma Treatment Drug Obtained Drug Registration Certificate Breaking Through the Blue Ocean of The Ophthalmic Market Segment
March 4, 2021
VOLUNTARY ANNOUNCEMENT: FIRST PATIENT DOSED IN THE PHASE 1B CLINICAL TRIAL FOR SEPSIS OF THE GROUP FIRST-IN-CLASS DRUG STC3141
March 3, 2021
VOLUNTARY ANNOUNCEMENT: DRUG REGISTRATION CERTIFICATE FOR BIMATOPROST EYE DROPS WAS ISSUED
March 3, 2021
China Grand Pharmaceutical and Healthcare : GP (HK) Announces Positive Profit Alert the Expected Increase in Consolidated Net Profit Attributable to Owners of the Company for FY2020 No Less Than 40%
February 22, 2021
China Grand Pharmaceutical and Healthcare : GP (HK) and eTheRNA Enters into Exclusive Strategic Cooperation and Licensing Agreement on World-class Innovative Products in Greater China
November 30, 2020